The RNA decoys YBX1–1 and YBX1–2 specifically target YB-1, which prevents YB-1 from binding to the relevant mRNA and thus inhibits the activation of downstream oncogenes, resulting in slower tumour growth and better survival (130). The gene discussed is YBX1; the disease is neoplasm.